Literature DB >> 10862748

Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution.

A V Nguyen1, J W Pollard.   

Abstract

Involution of the mammary gland following weaning is divided into two distinct phases. Initially, milk stasis results in the induction of local factors that cause apoptosis in the alveolar epithelium. Secondly after a prolonged absence of suckling, the consequent decline in circulating lactogenic hormone concentrations initiates remodeling of the mammary gland to the virgin-like state. We have shown that immediately following weaning TGFbeta3 mRNA and protein is rapidly induced in the mammary epithelium and that this precedes the onset of apoptosis. Unilateral inhibition of suckling and hormonal reconstitution experiments showed that TGFbeta3 induction is regulated by milk stasis and not by the circulating hormonal concentration. Directed expression of TGFbeta3 in the alveolar epithelium of lactating mice using a beta-lactoglobulin promoter mobilized SMAD4 translocation to the nucleus and caused apoptosis of these cells, but not tissue remodeling. Transplantation of neonatal mammary tissue derived from TGFbeta3 null mutant mice into syngenic hosts resulted in a significant inhibition of cell death compared to wild-type mice upon milk stasis. These results provide direct evidence that TGFbeta3 is a local mammary factor induced by milk stasis that causes apoptosis in the mammary gland epithelium during involution.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862748     DOI: 10.1242/dev.127.14.3107

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  75 in total

1.  Non-redundant tumour supressor functions of transforming growth factor beta in breast cancer.

Authors:  M Azhar
Journal:  J Biosci       Date:  2001-03       Impact factor: 1.826

Review 2.  TGF-beta signaling in mammary gland development and tumorigenesis.

Authors:  L M Wakefield; E Piek; E P Böttinger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

3.  PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer.

Authors:  Joshua VanHouten; Catherine Sullivan; Caroline Bazinet; Tom Ryoo; Robert Camp; David L Rimm; Gina Chung; John Wysolmerski
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

Review 4.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

5.  Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution.

Authors:  Michael C Rudolph; James L McManaman; Larry Hunter; Tzulip Phang; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 6.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 7.  Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer.

Authors:  Celeste M Nelson; Mina J Bissell
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 8.  Mammary gland involution as a multi-step process.

Authors:  Torsten Stein; Nathan Salomonis; Barry A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

9.  Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.

Authors:  Sang Gyun Kim; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Noe Kyeong Kim; Seung Hwan Hong; Yung-Jue Bang
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

Review 10.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.